12 results · 23ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

BD Touchless™ Plus Unisex Pre-Lubricated Urethral Catheter Kit

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

MIRROR SUCTION Double Sided HEAD (1)

FDA UDI
HAGER WORLDWIDE, INC.·00014081540768·mirror suction double sided evacuation tip head...

MIRROR SUCTION Double Sided HEAD (1)

FDA UDI
HAGER WORLDWIDE, INC.·D2482540760·mirror suction double sided evacuation tip head...

NA

FDA UDI
Stryker Leibinger GmbH & Co. KG·07613154546480·COMPRESSION PLATE, ANGLED, FOR 2.0MM

EsCem

FDA 510(k)
FDA Class 2 ·Dental

iCare ALTIUS CW

FDA 510(k)
FDA Class 2 ·Radiology

CURLIN PUMP 6000 CMS

FDA Adverse Event
Malfunction ·MOOG COSTA RICA, SRL·Product code FRN·October 26, 2022

VITALITY EL

FDA Adverse Event
Malfunction ·CARDIAC PACEMAKERS, INC·Product code LWS·November 11, 2008

ASR ACETABULAR CUPS 50

FDA Adverse Event
Injury ·DEPUY INTERNATIONAL·Product code KWA·September 19, 2011

NEXGEN LPS-FLEX FEMORAL COMPONENT

FDA Adverse Event
Injury ·ZIMMER, INC.·Product code NJL·July 26, 2013

ACCOLADE DR SL MRI (Model L311)

FDA Enforcement
Class I ·Ongoing·Boston Scientific Corporation·October 22, 2025

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014